Cargando…

Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets

BACKGROUND: Malignant peripheral nerve sheath tumour (MPNST) is an aggressive orphan disease commonly affecting adolescents or young adults. Current knowledge of molecular tumour biology has been insufficient for development of rational treatment strategies. We aimed to discover molecular subtypes o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Høland, Maren, Berg, Kaja C.G., Eilertsen, Ina A., Bjerkehagen, Bodil, Kolberg, Matthias, Boye, Kjetil, Lingjærde, Ole Christian, Guren, Tormod K., Mandahl, Nils, van den Berg, Eva, Palmerini, Emanuela, Smeland, Sigbjørn, Picci, Piero, Mertens, Fredrik, Sveen, Anita, Lothe, Ragnhild A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585232/ https://www.ncbi.nlm.nih.gov/pubmed/37837931 http://dx.doi.org/10.1016/j.ebiom.2023.104829

Ejemplares similares

Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
por: Danielsen, Stine A., et al.
Publicado: (2015)

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
por: Kolberg, Matthias, et al.
Publicado: (2013)

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection
por: Kolberg, Matthias, et al.
Publicado: (2015)

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
por: Berg, Kaja C. G., et al.
Publicado: (2019)

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
por: Smeby, Jørgen, et al.
Publicado: (2020)

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
por: Kolberg, Matthias, et al.
Publicado: (2017)

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection
por: Sveen, Anita, et al.
Publicado: (2016)

Frequent copy number gains of SLC2A3 and ETV1 in testicular embryonal carcinomas
por: Hoff, Andreas M, et al.
Publicado: (2020)

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
por: Moosavi, Seyed H., et al.
Publicado: (2021)

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties
por: Eide, Peter W., et al.
Publicado: (2019)

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
por: Bruun, Jarle, et al.
Publicado: (2018)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

CMS-dependent prognostic impact of KRAS and BRAF(V600E) mutations in primary colorectal cancer
por: Smeby, J, et al.
Publicado: (2018)

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
por: Berg, Kaja C. G., et al.
Publicado: (2017)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma
por: Nyquist, Kaja B., et al.
Publicado: (2012)

Genomic and prognostic heterogeneity among RAS/BRAF (V600E)/TP53 co‐mutated resectable colorectal liver metastases
por: Berg, Kaja C. G., et al.
Publicado: (2021)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
por: Smeland, Sigbjørn, et al.
Publicado: (2011)

A robust internal control for high-precision DNA methylation analyses by droplet digital PCR
por: Pharo, Heidi D., et al.
Publicado: (2018)

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
por: Namløs, Heidi M., et al.
Publicado: (2017)

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
por: Bergsland, Christian H, et al.
Publicado: (2020)

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
por: Kresse, Stine H, et al.
Publicado: (2008)

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
por: Kryeziu, Kushtrim, et al.
Publicado: (2021)

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas
por: Sveen, Anita, et al.
Publicado: (2014)

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
por: Boye, Kjetil, et al.
Publicado: (2021)

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
por: Gorunova, Ludmila, et al.
Publicado: (2022)

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011)

Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
por: Bergsland, Christian H., et al.
Publicado: (2022)

Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
por: Berndsen, Marta, et al.
Publicado: (2023)

The expressed mutational landscape of microsatellite stable colorectal cancers
por: Sveen, Anita, et al.
Publicado: (2021)

Exome Sequencing of Bilateral Testicular Germ Cell Tumors Suggests Independent Development Lineages()()
por: Brabrand, Sigmund, et al.
Publicado: (2015)

Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
por: Bjerkehagen, B, et al.
Publicado: (2012)

Malignancy in Giant Cell Tumor of Bone: A Review of the Literature
por: Palmerini, Emanuela, et al.
Publicado: (2019)

Pulsatile Dynamics of the Optic Nerve Sheath and Intracranial Pressure: An Exploratory In Vivo Investigation
por: Padayachy, Llewellyn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9peebjtplk2qigi3o1103jjf94